“`html
TransMedics Group’s Market Performance
TransMedics Group (NASDAQ: TMDX) has seen its stock price triple from 2023 lows following an acquisition of Summit Aviation in August 2023, despite initial skepticism. The company’s revenue from organ transplants increased by 32%, and logistics revenue rose by 35%, with a net profit margin of 17%. TransMedics aims to double its transplants to 10,000 in the coming years and expand into kidney donation and international markets.
Historical Context and Lessons Learned
The author reflects on early investment decisions, notably concerning Amazon’s (NASDAQ: AMZN) Fire Phone in 2014, which he initially viewed negatively but resulted in Amazon’s stock becoming a “14-bagger.” He emphasizes the importance of patience in allowing founder-led companies to innovate and execute their long-term visions.
“`
